[EN] PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS [FR] COMPOSÉS PHARMACEUTIQUES POUR LE TRAITEMENT DE TROUBLES MÉDIÉS PAR LE COMPLÉMENT
摘要:
This disclosure provides compounds, compositions, and methods to treat medical disorders, such as complement-mediated disorders, including complement C1s-mediated disorders.
Derivatives of purine, their preparation process and pharmaceutical compositions containing them
申请人:Haesslein Jean-Luc
公开号:US20050187228A1
公开(公告)日:2005-08-25
A compound of the formula
wherein R is defined as in the specification, which compounds have an inhibitory effect vis-à-vis cycline-dependent kinase proteins (cdk) and are endowed with antimitotic properties.
Direct and Chemoselective Electrophilic Monofluoromethylation of Heteroatoms (<i>O</i>-, <i>S-</i>, <i>N</i>-, <i>P</i>-, <i>Se</i>-) with Fluoroiodomethane
作者:Raffaele Senatore、Monika Malik、Markus Spreitzer、Wolfgang Holzer、Vittorio Pace
DOI:10.1021/acs.orglett.9b04654
日期:2020.2.21
The commercially available fluoroiodomethane represents a valuable and effective electrophilic source for transferring the CH2F unit to a series of heteroatom-centered nucleophiles under mild basic conditions. The excellent manipulability offered by its liquid physical state (bp 53.4 °C) enables practical and straightforward one-step nucleophilic substitutions to retain the chiral information embodied